Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for ...

clinepi.mcgill.ca Background: Inhaled corticosteroids are effective at preventing asthma morbidity and mortality. Most studies, however, have focused on short term effects, raising uncertainty about ...

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...

Narasimhan K. Am Fam Physician. 2021;103:286–9 ii Skov IR, Madsen H, et al. Low-dose oral corticosteroids in asthma associates with increased morbidity ...

The following is a summary of “Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor ...

Recently, tiotropium has been studied in asthma, when added to low-dose inhaled corticosteroids in unselected moderate asthmatics or in patients with uncontrolled asthma, or patients with chronic ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...

When asthma symptoms like these can't be controlled with daily medication, the condition is considered severe. Severe asthma is usually treated with inhaled corticosteroids and often other long-term ...

Background: Previous studies have indicated the benefits of adding long acting β 2 agonists to inhaled corticosteroids in the maintenance treatment of moderate to severe asthma. The effects of adding ...